Access to Medicine Foundation - Closing the health equity gap
Access to medicine should never depend on where a person lives. Yet for millions of people in low- and middle-income countries, lifesaving medicines, vaccines, antibiotics, diagnostics and other essential health products, including those critical for women and children, remain out of reach. Â
As health systems around the world face growing challenges, including drug-resistant infections, rising rates of heart disease and cancer, and the threat of future pandemics, the need to close healthcare access gaps has never been more urgent.Â
Our approach
For more than 20 years, the Access to Medicine Foundation has served as an independent, non-profit catalyst for change, tracking, benchmarking and guiding the world’s most influential pharmaceutical companies to expand access to essential healthcare products for the people who that need them most, regardless of where they live.Â
The value we bring
2.6M deaths averted & 808M patients reached by 2030 Â
~$60 USD return per $1 invested 
Our proven model of changeÂ
The Access to Medicine Foundation drives change through a multi-faceted model that combines rigorous research, engagement with pharmaceutical and healthcare companies to identify opportunities to expand access and unleashing the power of institutional investors and governments to drive impact. To date, over 145 investors managing assets of more than USD 22 trillion use our data and insights to advance access. Â
By bringing together key stakeholders across the global health ecosystem, the Foundation helps turn commitments into measurable action.Â
The opportunity for change Â
The Access to Medicine Foundation works across some of the world's most pressing health challenges, including antimicrobial resistance, diabetes, cancer, maternal and child health, infectious diseases and other global health priorities. Â
The Foundation’s flagship publication, the Access to Medicine Index, which spans more than 80 diseases and conditions and 113 underserved countries, zeroes in on specific opportunities for the industry to address persistent gaps and captures best practices that can be leveraged by other influential players to drive change. This powerful tool is not just for companies, but also for governments and investors, who are essential partners in the effort to make global health equity a reality.Â
Invest in accessÂ
Whether you are an individual, philanthropist, or an organisation, your contribution will help scale our evidence-based research and change-making efforts, resulting in access to essential medicines for the people who need them most. By advancing access to essential healthcare products, together we can help people living in low-and middle-income countries live healthier lives and build stronger futures for themselves, their families and their communities.Â
To learn how your support can help accelerate access to essential healthcare products for people living in low- and middle-income countries, please contact Jayasree K. Iyer, CEO, Access to Medicine Foundation.Â
Donate today to make essential medicines accessible to everyone, everywhere.
Margo Warren
Director of Government Engagement & Policy
mwarren@Accesstomedicinefoundation.org
Get in touch